Vistagen Therapeutics (VTGN)
Nasdaq • VTGN • US92840H4002
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 6.5% of free float sold short, 1.7 days to cover, cost to borrow 5.14%. Sign up for live short interest data.
Market Cap
7.4m USD | # 11539 in US
Volume
10.27m shares | 2.43m USD
Shares Outstanding
44.38m
Free Float Shares
93.34% | 41.42m
